Immunotherapy Shows Encouraging Results in NeuroblastomaImmunotherapy Shows Encouraging Results in Neuroblastoma
An experimental monoclonal antibody, added to chemotherapy, achieved an 89% response rate in a small early study. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Chemotherapy | Hematology | Immunotherapy | Neuroblastoma | Neurology | Study